Zenas BioPharma, Inc. Class Action Lawsuit - ZBIO

Company
Zenas BioPharma, Inc. (NASDAQ: ZBIO)
Lead Plaintiff Deadline
June 16, 2025 (Expired)
Class Definition
This lawsuit is on behalf of persons who purchased or otherwise acquired Zenas BioPharma securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Zenas BioPharma’s September 2024 initial public offering.

Expired

Lead Plaintiff Deadline

Jun 16, 2025

Never Miss Another Deadline

Choose your preferred way to stay informed of new case launches and settlement deadlines

WhatsApp

Scan the QR code or click the button to join

Join on WhatsApp

Get Updates by Email

Required Field

Required Field

Required Field

No Spam, opt-out anytime, alert list is free

Allegations

The filed complaint alleges that Zenas BioPharma, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Zenas BioPharma materially overstated the amount of time that it would be able to fund its operations using existing cash and expected net proceeds from the IPO; and (2) as a result, defendants’ public statements were materially false and misleading at all relevant times and negligently prepared.

Eligibility

In order to be eligible to join the ZBIO class action lawsuit, you must have incurred a loss on shares of Zenas BioPharma, Inc. purchased during the class period listed above.

Lead Plaintiff Deadline

If you suffered a loss in Zenas BioPharma, Inc. during the relevant time frame, you have until June 16, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

TOP